The c-Jun-induced transformation process involves complex regulation of tenascin-C expression

Molecular and Cellular Biology

Volumn 17, Issue 6, 1997, Pages 3202-3209

  Mettouchi, Amel ^a   Cabon, Florence ^a   Montreau, Nicole ^a   Dejong, Valérie ^a   Vernier, Philippe ^b   Gherzi, Roberto ^c   Mercier, Gilles ^a   Binétruy, Bernard ^a  

^a CNRS UPR9079 Oncogenese Differenciation et T   (France)

^b CNRS   (France)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; OSTEONECTIN; SCLEROPROTEIN; TENASCIN; THROMBOSPONDIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR MATRIX; FIBROBLAST; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; NONHUMAN; ONCOGENE C JUN; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0030977167     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.6.3202     Document Type: Article

References (57)

1. Alani, R., P. Brown, B. Binétruy, H. Dosaka, R. Rosenberg, P. Angel, M. Karin, and M. Birrer. 1991. The transactivating domain of the c-jun protooncogene is required for cotransformation of rat embryo cells. Mol. Cell. Biol. 11:6286-6295.
2. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
3. Angel, P., I. Baumann, B. Stein, H. Delius, H. J. Rahmsdorf, and P. Herrlich. 1987. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7:2256-2266.
4. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
5. Arndt, K., and G. Fink. 1986. GCN4 protein, a positive transcription factor in yeast, binds general control promoters at all 5′ TGACTC 3′ sequences. Proc. Natl. Acad. Sci. USA 83:8516-8520.
6. Aukhil, I., P. Joshi, Y. Yan, and H. Erickson. 1993. Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins. J. Biol. Chem. 268:2542-2553.
7. Ausubel, F., R. Brent, R. Kingston, D. Moore, J. G. Seidman, J. Smith, and K. Struhl (ed.). 1994. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y.
8. Bengal, E., L. Ransone, R. Scharfmann, V. Dwarki, S. Tapscott, H. Weintraub, and I. Verma. 1992. Functional antagonism between c-Jun and myoD proteins: a direct physical association. Cell 68:507-519.
9. Binétruy, B., T. Smeal, and M. Karin. 1991. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351:122-127.
10. Bohman, D., T. Bos, A. Admon, T. Nishimura, P. Vogt, and R. Tjian. 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcriptional factor AP-1. Science 238: 1386-1392.
11. Borsi, L., B. Carnemolla, G. Nicolò, B. Spina, G. Tanara, and L. Zardi. 1992. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer 52:688-692.
12. Bos, T., F. Monteclaro, F. Mitsunobu, A. Ball, C. Chang, T. Nishimura, and P. Vogt. 1990. Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. Genes Dev. 4:1677-1687.
13. Bossy-Wetzel, E., R. Bravo, and D. Hanahan. 1992. Transcription factors JunB and c-Jun are selectively up-regulated and functionally implicated in fibrosarcoma development. Genes Dev. 6:2340-2351.
14. Boyle, W. J., T. Smeal, L. Defize, P. Angel, J. Woodget, M. Karin, and T. Hunter. 1991. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA binding activity. Cell 64:573-584.
15. Brou, C., and A. Israel. Unpublished results.
16. Cano, E., C. Hazzalin, and L. Mahadevan. 1994. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell. Biol. 14:7352-7362.
17. Carnemolla, B., L. Borsi, G. Bannikov, S. Troyanovsky, and L. Zardi. 1992. Comparison of human tenascin expression in normal, simian-virus-40-transformed and tumor-derived cell lines. Eur. J. Biochem. 205:561-567.
18. Castellazzi, M., J. P. Dangy, F. Mechta, S. I. Hirai, M. Yaniv, J. Samarut, A. Lassailly, and G. Brun. 1990. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partial transformed phenotype. Oncogene 5:1541-1547.
19. Chiquet-Ehrismann, R., E. Mackie, A. Pearson, and T. Sakakura. 1986. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131-139.
20. Chiu, R., W. J. Boyle, J. Meek, T. Smeal, T. Hunter, and M. Karin. 1988. The c-Fos protein interacts with c-Jun/AP1 to stimulate transcription of AP1 responsive genes. Cell 54:541-552.
21. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
22. Crossin, K. 1991. Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinization in fibroblasts. Proc. Natl. Acad. Sci. USA 88: 11403-11407.
23. Dent, C. L., and D. S. Latchman. 1993. The DNA mobility shift assay, p. 1-26. In D. S. Latchman (ed.), Transcription factor, a practical approach. IRL Press, New York, N.Y.
24. Desbois, C., D. Aubert, C. Legrand, B. Pain, and J. Samarut. 1991. A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell 67: 731-740.
25. End, P., G. Panayotou, A. Entwistle, M. Waterfield, and M. Chiquet. 1992. Tenascin: a modulator of cell growth. Eur. J. Biochem. 209:1041-1051.
26. Erickson, H. 1993. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol. 5:869-876.
27. Erickson, H., and M. Bourdon. 1989. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol. 5:71-92.
28. Gherzi, R., B. Carnemolla, A. Siri, M. Ponassi, E. Balza, and L. Zardi. 1995. Human tenascin gene. J. Biol. Chem. 270:3429-3434.
29. Ham, J., C. Babij, J. Whitfield, C. Pfarr, D. Lallemand, M. Yaniv, and L. Rubin. 1995. A c-Jun dominant negative mutant protects sympathetic neurons against programmed death. Neuron 14:927-939.
30. Hiraiwa, N., H. Kida, T. Sakakura, and M. Kusakabe. 1993. Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusable factor. J. Cell Sci. 104:289-296.
31. Husman, K., A. Faissner, and M. Schachner. 1992. Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats. J. Cell Biol. 116:1475-1486.
32. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483-16486.
33. Karin, M., and T. Hunter. 1995. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5:747-757.
34. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M. Urban, P. Kourilsky, P. Bauerle, and A. Israël. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007-1018.
35. Joshi, P., C.-Y. Chung, I. Aukhil, and H. Erickson. 1993. Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin. J. Cell Sci. 106:389-400.
36. Lochter, A., L. Vaughan, A. Kaplony, A. Prochiantz, M. Schachner, and A. Faissner. 1991. J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J. Cell Biol. 113:1159-1171.
37. Mackie, E., W. Halfter, and D. Liverani. 1988. Induction of tenascin in healing wounds. J. Cell Biol. 107:2757-2767.
38. Mackie, E., R. Chiquet-Ehrismann, C. Adams Pearson, Y. Inaguma, K. Taya, Y. Kawarada, and T. Sakakura. 1987. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. Natl. Acad. Sci. USA 84:4621-4625.
39. Mettouchi, A., F. Cabon, N. Montreau, P. Vernier, G. Mercier, D. Blangy, H. Tricoire, P. Vigier, and B. Binétruy. 1994. SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts. EMBO J. 13:5668-5678.
40. Nolan, G. 1994. NF-AT-AP-1 and Rel-bZIP: hybrid vigor and binding under the influence. Cell 77:795-798.
41. Prieto, A., C. Andersson-Fisone, and K. Crossin. 1992. Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin. J. Cell Biol. 119:663-678.
42. Saga, Y., T. Tsukamoto, N. Jing, M. Kusakabe, and T. Sakakura. 1991. Murine tenascin: cDNA cloning, structure and temporal expression of isoforms. Gene 104:177-185.
43. Saga, Y., T. Yagi, Y. Ykawa, T. Sakakura, and S. Aizawa. 1992. Mice develop normally without tenascin. Genes Dev. 6:1821-1831.
44. Schmitz, L., and P. Bauerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805-3817.
45. Schütte, J., J. D. Minna, and M. Birrer. 1989. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms Rat-1 cells as a single gene. Proc. Natl. Acad. Sci. USA 86:2257-2261.
46. Sharifi, B., D. LaFleur, C. Pirola, J. Forrester, and J. Fagin. 1992. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J. Biol. Chem. 267:23910-23915.
47. Smeal, T., B. Binétruy, D. Mercola, M. Birrer, and M. Karin. 1991. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354:494-496.
48. Stein, B., A. Baldwin, Jr., D. Ballard, W. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891.
49. Steindler, D. A., D. Settles, H. Erickson, E. D. Laywell, A. Yoshiki, A. Faissner, and M. Kusakabe. 1995. Tenascin knockout mice: barrels, boundary molecules, and glial scars. J. Neurosci. 1504:1971-1983.
50. Struhl, K. 1987. The DNA-binding domains of the jun oncoprotein and the yeast GCN4 transcriptional activator protein are functionally homologous. Cell 50:841-846.
51. Vandel, L., N. Montreau, E. Vial, C. Pfarr, B. Binétruy, and M. Castellazzi. 1996. Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation but a c-Jun-containing heterodimer is required for immortalization. Mol. Cell. Biol. 16:1881-1888.
52. Vincent, S., L. Marty, and P. Fort. 1993. S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eukaryotic cells and tissues. Nucleic Acids Res. 21:1498.
53. Vogt, P., and T. Bos. 1990. Jun: oncogene and transcription factor. Adv. Cancer Res. 55:1-35.
54. Wehrle, B., and M. Chiquet. 1990. Tenascin is accumulated along developing peripheral nerves and allows neurite outgrowth in vitro. Development 110: 401-415.
55. Xia, Z., M. Dickens, J. Raingeaud, R. Davis, and M. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
56. Yang-Yen, H., J. C. Chambard, Y. Sun, T. Smeal, T. Schmidt, J. Drouin, and M. Karin. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
57. Zohn, I., H. Yu, X. Li, A. Cox, and S. Earp. 1995. Angiotensin II stimulates calcium-dependent activation of c-Jun terminal kinase. Mol. Cell. Biol. 15: 6110-6118.